Delivery Order SPE2DB25D3306-SPE2DB25FUCSC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,523.02 for Protonix 40 mg suspension (30-count) with an ultimate completion date of July 21, 2025. This firm fixed-price contract, awarded on July 18, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- This federal contract award is for the delivery of PROTONIX 40 MG SUSPENSION 30S to the Defense Logistics Agency, a defense agency. The $6,674.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for PROTONIX DR 40 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $1,760.02 and a performance period through March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and this order falls under an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,429.01 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, calls for the delivery of Pantoprazole DR 40 mg suspension packets in quantities of 30. This delivery order represents a child...
- The Defense Logistics Agency awarded a $230,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PROTONIX 40 MG SUSPENSION 30S. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania location to the Defense Logistics Agency by July 31, 2023 to support the agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency is the Department of Defense's combat logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pantoprazole DR 40 mg Suspension Packets (30 count) with a ceiling value of $3,200.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a continuation of...
- The Defense Logistics Agency awarded a $89,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 4561815530 units of the proton pump inhibitor drug Protonix IV in 40mg vials. The single day order from August 15-16, 2023 will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania to support the Department of Defense's medical supply needs. As a top tier subcontractor to DLA's prime vendor programs, Amerisourcebergen regularly provides...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PROTONIX IV 40 MG VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,626.10 and an ultimate completion date of January 17, 2025. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $1,754 to supply 4561731721 units of the drug Protonix IV in 40mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 7 through August 8, 2023. The Defense Logistics Agency functions to support the logistical needs of the U.S. Department of Defense and coordinates procurement and distribution...
- The Defense Logistics Agency awarded a $666.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561805341 Protonix IV 40mg vials. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its Conshohocken, Pennsylvania location to the Defense Logistics Agency. The delivery order has a period of performance from August 14, 2023 through August 15, 2023. No subcontractors or set aside designations were identified. The Defense...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCSCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,591.48 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. This delivery order exemplifies the operational scope of the DLA's pharmaceutical supply chain, wherein AmerisourceBergen fulfills routine medical product requirements across the federal healthcare system. The underlying SPE2DX contract enables flexible procurement of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. As a prime contractor demonstrating consistent capability to meet federal procurement standards through open competition, AmerisourceBergen continues to play a significant role in the DLA's strategic pharmaceutical supply strategy, with potential expansion through the planned Pharmaceutical Prime Vendor Global Program Generation V contracts, which will make multiple awards across separate geographic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/22/25 |